Henry Staines

Lecturer

St George’s, University of London

United Kingdom

Research Interests

Explore related searches

Professors in United Kingdom

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Henry Staines is a Lecturer at St. George's University of London, UK. His research primarily focuses on patient preference in cervical screening, rapid detection methods for COVID-19, and drug repurposing related to the pandemic. He has contributed to various studies, including the immunogenicity of SARS-CoV-2 vaccines in patients with gastrointestinal cancer and the identification of new inhibitors for Plasmodium falciparum ATPase 6.

Articles (11)

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Year:

2020

Collaborators (7)

Thirumalaisamy P Velavan

Akademischer Oberrart/Professor

Universitätsklinikum Tübingen

GERMANY

View details

Pedro Eduardo Ferreira

University of Minho

PORTUGAL

View details

Emanuele Giorgi

University of Lancaster

UNITED KINGDOM

View details

Stefanie Menzies

University of Lancaster

UNITED KINGDOM

View details

Luis E. Cuevas

Professor International Health and Epidemiology

Liverpool School of Tropical Medicine

UNITED KINGDOM

View details

Sanjeev Krishna

University College London

UNITED KINGDOM

View details

Sophie Owen

University of Oxford

UNITED KINGDOM

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Henry Staines

Research Interests

Explore related searches

Contact this professor

About

Articles (11)

Patient preference and acceptability of self-sampling for cervical screening in colposcopy clinic attenders: A cross-sectional semi-structured survey

The QuantuMDx Q-POC SARS-CoV-2 RT-PCR assay for rapid detection of COVID-19 at point-of-care: preliminary evaluation of a novel technology

Drug repurposing for COVID-19: current evidence from randomized controlled adaptive platform trials and living systematic reviews

SARS-CoV-2 Vaccine Immunogenicity in Patients with Gastrointestinal Cancer Receiving Systemic Anti-Cancer Therapy.

Selective Inhibition of Plasmodium falciparum ATPase 6 by Artemisinins and Identification of New Classes of Inhibitors after Expression in Yeast.

SARS-CoV-2 enzyme-linked immunosorbent assays as proxies for plaque reduction neutralisation tests.

Prevalence of neutralising antibodies against SARS-CoV-2 in acute infection and convalescence: A systematic review and meta-analysis

Self-sampling of capillary blood for SARS-CoV-2 serology.

IgG Seroconversion and Pathophysiology in Severe Acute Respiratory Syndrome Coronavirus 2 Infection.

Repurposing Antimalarials to Tackle the COVID-19 Pandemic.

Artemisinins as a novel anti-cancer therapy: Targeting a global cancer pandemic through drug repurposing.

Collaborators (7)

Thirumalaisamy P Velavan

Pedro Eduardo Ferreira

Emanuele Giorgi

Stefanie Menzies

Luis E. Cuevas

Sanjeev Krishna

Sophie Owen

Make your next move.